Tandem Diabetes Care

Tandem Diabetes Care

Health Care Equipment & Supplies
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

$1.2B

Market Cap • 9/14/2026

2008

(18 years)

Founded

2013

(13 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

9

P/S

1,1

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

1,9

EPS

Market Cap

Market Cap

1,2B

EV

1,5B

EV/Revenue

1,4

EV/EBITDA

-52,2

EV/EBIT

-31,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-1,3B

Profitability

Gross Margin

56%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

18%

Capex/Revenue

2%

Capex/D&A

117,4%

Capex/OCF

-381,9%

SBC/OCF

% PPE

16%

% Goodwill

0%

ROE

ROIC

Growth

CAGR Revenue 5Y

11,5%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

3,2

Quick Ratio

2,4

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium